IUPAC/Chemical Name
Benzoic acid, 4-amino-, butyl ester, mixt. with alkylbenzyldimethylammonium chlorides, 2-(dimethylamino)ethyl 4-(butylamino)benzoate monohydrochloride and ethyl 4-aminobenzoate
InChi Key
OMAFOCBRUMMGGS-UHFFFAOYSA-M
InChi Code
InChI=1S/C27H50N.C20H44N.C17H30N.C15H24N2O2.C11H15NO2.C9H11NO2.BrH.ClH/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-22-25-28(2,3)26-27-23-20-19-21-24-27;1-5-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21(3,4)6-2;1-4-5-6-7-8-12-15-18(2,3)16-17-13-10-9-11-14-17;1-4-5-10-16-14-8-6-13(7-9-14)15(18)19-12-11-17(2)3;1-2-3-8-14-11(13)9-4-6-10(12)7-5-9;1-2-12-9(11)7-3-5-8(10)6-4-7;;/h19-21,23-24H,4-18,22,25-26H2,1-3H3;5-20H2,1-4H3;9-11,13-14H,4-8,12,15-16H2,1-3H3;6-9,16H,4-5,10-12H2,1-3H3;4-7H,2-3,8,12H2,1H3;3-6H,2,10H2,1H3;2*1H/q3*+1;;;;;/p-1
SMILES Code
CCCCCCCCCCCCCCCCCC[N+](C)(Cc1ccccc1)C.CCCCCCCCCCCCCCCC[N+](C)(CC)C.CCCCCCCC[N+](C)(Cc2ccccc2)C.CCCCNc3ccc(C(OCCN(C)C)=O)cc3.CCCCOC(c4ccc(N)cc4)=O.CCOC(c5ccc(N)cc5)=O.Cl.[Br-]
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
1,674.88
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Khan R, Kuppaswamy BS. Cetacaine induced methemoglobinemia: overview of analysis and treatment strategies. W V Med J. 2013 May-Jun;109(3):24-6. PMID: 23798277.
2: Brignardello-Petersen R. Topical Cetacaine is probably more effective in preventing pain than benzocaine and an eutectic mixture of local anesthetic before palatal infiltration in children. J Am Dent Assoc. 2020 Oct;151(10):e88. doi: 10.1016/j.adaj.2020.04.011. Epub 2020 Jul 28. PMID: 32736797.
3: Mogos M, Thangathurai D, Roffey P, Tay C. Cetacaine-induced complication during transesophageal echocardiography placement. J Cardiothorac Vasc Anesth. 2010 Aug;24(4):736. doi: 10.1053/j.jvca.2009.06.018. Epub 2009 Aug 31. PMID: 19717315.
4: Ferraro L, Zeichner S, Greenblott G, Groeger JS. Cetacaine-induced acute methemoglobinemia. Anesthesiology. 1988 Oct;69(4):614-5. doi: 10.1097/00000542-198810000-00029. PMID: 3263064.
5: Gregory PJ, Matsuda K. Cetacaine spray-induced methemoglobinemia after transesophageal echocardiography. Ann Pharmacother. 2000 Sep;34(9):1077. doi: 10.1345/aph.19134a. PMID: 10981258.
6: Douglas WW, Fairbanks VF. Methemoglobinemia induced by a topical anesthetic spray (cetacaine). Chest. 1977 May;71(5):587-91. doi: 10.1378/chest.71.5.587. PMID: 856556.
7: Khanal S, Modi R, Akhtar K, Ghimire A. Benzocaine-Associated Methemoglobinemia. Am J Ther. 2018 Nov/Dec;25(6):e771-e772. doi: 10.1097/MJT.0000000000000782. PMID: 29912717.
8: Braden GC, Brice AK, Hankenson FC. Adverse effects of vapocoolant and topical anesthesia for tail biopsy of preweanling mice. J Am Assoc Lab Anim Sci. 2015 May;54(3):291-8. PMID: 26045455; PMCID: PMC4460942.
9: Seibert RW, Seibert JJ. Infantile methemoglobinemia induced by a topical anesthetic, Cetacaine. Laryngoscope. 1984 Jun;94(6):816-7. PMID: 6610085.
10: Sandza JG Jr, Roberts RW, Shaw RC, Connors JP. Symptomatic methemoglobinemia with a commonly used topical anesthetic, cetacaine. Ann Thorac Surg. 1980 Aug;30(2):187-90. doi: 10.1016/s0003-4975(10)61240-4. PMID: 6968187.
